Michael Erdle, Deeth Williams Wall LLP
Parimal Nathwani, MaRS Innovation
Mark Penner, Fasken Martineau DuMoulin LLP
Please join us for a lively and insightful panel discussion focused on uneven bargaining power in licensing negotiations – what is it, how does it manifest, and what are the practical steps you and/or your client can take to maximize the likelihood and scope of a favourable outcome.
Generally, the session will be divided to cover the following topics:
There will be short presentations by our panelists followed by plenty of time for questions and open discussion.
- Defining uneven bargaining power and a discussion of how the landscape has been evolving over the last ten or twenty years
- Tactics and strategies to employ before entering into negotiations with Big Pharma/Tech
- What to expect and how to deal with difficult situations during the negotiation process
LES Member: $20 CAD
Non-Member: $30 CAD
Onsite registration is available.
Lunch will be provided.
Michael Erdle is a commercial lawyer, mediator and arbitrator. Over the past 30 years, he has helped clients negotiate countless license agreements. He currently acts as a facilitator and mediator to negotiate the resolution of licensing disputes. Michael also teaches a course on "More Powerful Negotiation Skills” at University of Toronto School of Continuing Studies. He is the founder of Practical Resolutions Inc. (www.practicalresolutions.ca) where he acts as an independent facilitator, mediator and arbitrator for a wide range of commercial disputes. He can be reached at firstname.lastname@example.org.
Parimal Nathwani is the Vice President of Life Sciences at MaRS Innovation. He has more than a decade of experience in various aspects of the biotechnology industry, including finance, intellectual property management, business development and operations; he has been actively involved in preparing business plans, forming start-up companies, raising early-stage capital, managing intellectual-property portfolios and out-licensing initiatives. Parimal was a healthcare analyst with a boutique investment bank, where he conducted due diligence on publicly-traded biotechnology companies in Canada and the U.S. for an institutional investor client base and advised companies on financing strategies. He has also held the position of technology transfer manager in the life sciences at one of Canada’s leading technology transfer offices.
Mark Penner is an intellectual property lawyer with Fasken Martineau DuMoulin’s Technology and Intellectual Property practice groups. Mark’s practice focuses on all aspects of the acquisition, protection, enforcement and strategic use of a wide range of intellectual property assets in Canada and around the world.